Top 5 Performing Stocks To Buy Right Now: NuPathe Inc.(PATH)
NuPathe Inc., a specialty pharmaceutical company, focuses on the development and commercialization of branded therapeutics for diseases of the central nervous system, including neurological and psychiatric disorders. The company?s advanced product candidate includes Zelrix an active single-use transdermal sumatriptan patch that is used for the treatment of migraine. Its proprietary product candidates in preclinical development stage comprise NP201 for the continuous symptomatic treatment of Parkinson?s disease; and NP202 for the long-term treatment of schizophrenia and bipolar disorder. NuPathe Inc. was founded in 2005 and is headquartered in Conshohocken, Pennsylvania.
Advisors' Opinion:- [By Vanina Egea] lli revealed owning a stake of 1,313,500 NuPathe Inc. shares, worth 0.01% of his portfolio. NuPathe Inc. has a market cap of $142 million; its shares are trading currently at around $4.3 with a P/B ratio of 18.4.
NuPathe is a specialty pharmaceutical company, focusing on the development and commercialization of branded therapeutics for neurological and psychiatric disorders. Teva Pharmaceutical Industries Ltd. (TEVA) announced a tender offer for all of the outstanding shares of common stock at a price of $3.65 per share in cash, and NuPathe stockholders will receive rights to receive additional cash payments of up to $3.15 per share The firm will become a wholly owned subsidiary of Teva, and common stock will cease to be traded on the Nasdaq following completion of the merger.
Hedge fund gurus have also been active in the company: Jim Simons (Trades, Portfolio) and Ronald Muhlenkamp (Trades, Portfolio) have invested in it.
ATMI Inc. (ATMI)
Gabelli reported a stake of 1,193,900 shares of ATMI Inc., sized at 0.22% of his portfolio, and 3.75% of the company. It has a market cap of $1.08 billion; its shares are trading at $34.04 with a P/E ratio of 28.6 and P/S ratio of 2.77.!
ATMI supplies high performance materials, materials packaging and materials delivery systems for use in the manufacture of microelectronics devices worldwide. ATMI agreed to be acquired by Entegris (ENTG) for $1.15 billion, or $34 per share. The deal will provide a lot more of product offerings. The acquisition is expected to close during the second calendar quarter of 2014.
Hedge fund gurus have also been active in the company. Jim Simons (Trades, Portfolio), Arnold Schneider (Trades, Portfolio) and Paul Tudor Jones (Trades, Portfolio) have divested in it in the last quarter.
Nobility Homes Inc. (NOBH)
Finally, Gabelli reported owning 234.950 shares of Nobility Homes, sized at 5.97% of the companys shares outstanding and 0.01% of Gabelli
source from Top Penny Stocks For 2015:http://www.topstocksforum.com/top-5-performing-stocks-to-buy-right-now-3.html
No comments:
Post a Comment